Bioequivalence of Empagliflozin/Metformin (12.5mg/500mg) Fixed Dose Combination Tablets Compared to Tablets Administered Together in Healthy Male and Female Volunteers Under Fed Conditions (an Open Label, Randomised, Single Dose, Two Period, Two Sequence Crossover Study)
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2015
At a glance
- Drugs Empagliflozin/metformin (Primary) ; Empagliflozin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 23 Jul 2015 Endpoints been amended.
- 09 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Feb 2014 Status changed from recruiting to active, no longer recruiting.